|
NCKAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.599000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.994000E-01 |
| Normal-vs-Stage2 |
5.857200E-01 |
| Normal-vs-Stage3 |
6.100200E-01 |
| Normal-vs-Stage4 |
9.465200E-01 |
| Stage1-vs-Stage2 |
5.299800E-01 |
| Stage1-vs-Stage3 |
5.205600E-01 |
| Stage1-vs-Stage4 |
9.434000E-01 |
| Stage2-vs-Stage3 |
8.709600E-01 |
| Stage2-vs-Stage4 |
5.713400E-01 |
| Stage3-vs-Stage4 |
5.851000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.595800E-01 |
| Normal-vs-AfricanAmerican |
3.558200E-01 |
| Normal-vs-Asian |
9.383600E-01 |
| Caucasian-vs-AfricanAmerican |
2.853600E-01 |
| Caucasian-vs-Asian |
7.476600E-01 |
| AfricanAmerican-vs-Asian |
4.738000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.138200E-01 |
| Normal-vs-Female |
9.090200E-01 |
| Male-vs-Female |
2.342400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.663000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.855800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.294200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.977000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.158800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.437000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.446800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.506400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.160800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.176600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.255400E-01 |
| Classical-VS-Follicular |
6.119600E-02 |
| Classical-VS-Other |
2.232400E-01 |
| Classical-VS-Normal |
6.451000E-01 |
| Tall-VS-Follicular |
9.045900E-02 |
| Tall-VS-Other |
8.666300E-02 |
| Tall-VS-Normal |
2.742000E-01 |
| Follicular-VS-Other |
6.213800E-01 |
| Follicular-VS-Normal |
2.911200E-01 |
| Other-VS-Normal |
2.176000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.663400E-01 |
| Normal-vs-N1 |
6.518400E-01 |
| N0-vs-N1 |
7.129800E-01 |
|
|
